No Data
Overview of the lifting of restrictions on the tradability of A-shares | February 24.
According to the Zhitong Finance App, on February 24, 20 listed companies had their restricted shares unlocked, with a total market value of approximately 10.741 billion yuan. The specific situation of the restricted shares unlocked today is as follows: Stock Abbreviation Stock Code Restricted Stock Type Unlocked Shares Luzhou Laojiao 000568 Stock-based Incentive 2.051 million Xiamen Xinde Co Ltd. 000701 Stock-based Incentive 0.172 million Shanzi Gaoke 000981 Other 2.988 billion YANKUANG ENERGY 600188 Stock-based Incentive 29.2178 million Anhui Tongfeng Electronics 600237 Additional issuance of A shares allocated to legal persons 17.192 million Zhejiang Hisun Pharmaceutical 60
Nanjing Pharmaceutical (600713.SH): 0.251 billion shares of restricted stock will be unlocked on February 21.
Gelonghui, February 14: Nanjing Pharmaceutical (600713.SH) announced that the total number of Stocks listed for circulation this time is 0.251 billion shares. The Stocks listing date is February 21, 2025.
Overview of the restrictive share release on A-shares | January 24th.
According to Zhitong Financial APP, on January 24, a total of 8 listed companies had their restricted stocks released, with a total market value of approximately 94.977 billion yuan. Today's specific situation for restricted stock release is as follows: Stock Abbreviation Stock Code Restricted Stock Type Released Shares Nanjing Pharmaceutical 600713 Stock-based Incentive Restricted Circulation 5.4028 million CHINA LONGYUAN 001289 Pre-issue Shares Restricted Circulation 4.909 billion Chongqing Baiya Sanitary Products 003006 Stock-based Incentive Restricted Circulation 0.677 million Meixin Technology 301577 Pre-issue Shares Restricted Circulation 7.746 million Snowsky Salt Industry Group 600929 Stock-based Incentive Restricted Circulation 0.5424 million Tianzheng Electric
Nanjing Pharmaceutical (600713.SH): Heling Pharmaceutical intends to adjust the leasing and renovate part of the factory buildings of Zhongshan Pharmaceutical.
On January 22, Gelonghui reported that Nanjing Pharmaceutical (600713.SH) announced that its holding subsidiary, Nanjing Pharmaceutical Co., Ltd. (referred to as "Nanjing Pharmaceutical"), plans to adjust the lease of part of the factory buildings from Nanjing Zhongshan Pharmaceutical Co., Ltd. (referred to as "Zhongshan Pharmaceutical") located at 21 Hengfa Road, Economic Development Zone, Nanjing, for warehousing and office purposes. After this adjustment, the total leased area for Heling Pharmaceutical Service Co., Ltd. (referred to as "Heling Pharmaceutical") will be 16,871.12 m2 (consistent with the currently leased area, with the specific area based on the real estate property certificate), with the lease term starting from 202.
Nanjing Pharmaceutical (600713.SH): "Nanjiao Convertible Bond" will be listed for Trade starting from January 20.
Nanjing Pharmaceutical (600713.SH) announced that the company's 1.081 billion yuan convertible Bonds will be issued on ...
Is NanJing Pharmaceutical (SHSE:600713) Using Too Much Debt?
What NanJing Pharmaceutical Company Limited's (SHSE:600713) ROE Can Tell Us